Anderson Schock
Stock Analyst at B. Riley Securities
(3.12)
# 2,689
Out of 4,501 analysts
37
Total ratings
60.6%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Reiterated: Buy | $10 | $4.64 | +115.52% | 1 | Jun 29, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $290 | $183.91 | +57.69% | 1 | Jun 26, 2026 | |
| CLPT ClearPoint Neuro | Maintained: Buy | $20 → $30 | $17.50 | +71.43% | 5 | Jun 17, 2026 | |
| VREX Varex Imaging | Reiterated: Buy | $18 | $11.05 | +62.90% | 4 | May 28, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $3.99 | +150.63% | 1 | May 18, 2026 | |
| ELMD Electromed | Maintained: Buy | $38 → $40 | $45.65 | -12.38% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Maintained: Buy | $11 → $10 | $6.41 | +56.01% | 4 | May 13, 2026 | |
| TCMD Tactile Systems Technology | Upgraded: Buy | $32 → $36 | $29.83 | +20.68% | 4 | May 7, 2026 | |
| BEAT HeartBeam | Initiated Coverage: Buy | $4 | $0.605 | +561.16% | 1 | Mar 31, 2026 | |
| XGN Exagen | Maintained: Buy | $8 | $4.45 | +79.78% | 4 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $18 | $15.60 | +15.38% | 3 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $10.42 | +34.36% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.89 | +164.55% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.54 | +114.07% | 3 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $9.68 | +23.97% | 2 | Nov 5, 2025 |
LifeMD
Jun 29, 2026
Reiterated: Buy
Price Target: $10
Current: $4.64
Upside: +115.52%
Nutex Health
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $290
Current: $183.91
Upside: +57.69%
ClearPoint Neuro
Jun 17, 2026
Maintained: Buy
Price Target: $20 → $30
Current: $17.50
Upside: +71.43%
Varex Imaging
May 28, 2026
Reiterated: Buy
Price Target: $18
Current: $11.05
Upside: +62.90%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $3.99
Upside: +150.63%
Electromed
May 13, 2026
Maintained: Buy
Price Target: $38 → $40
Current: $45.65
Upside: -12.38%
OptimizeRx
May 13, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $6.41
Upside: +56.01%
Tactile Systems Technology
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $29.83
Upside: +20.68%
HeartBeam
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.605
Upside: +561.16%
Exagen
Mar 11, 2026
Maintained: Buy
Price Target: $8
Current: $4.45
Upside: +79.78%
Feb 26, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $15.60
Upside: +15.38%
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.42
Upside: +34.36%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.89
Upside: +164.55%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $6.54
Upside: +114.07%
Nov 5, 2025
Maintained: Buy
Price Target: $12
Current: $9.68
Upside: +23.97%